X |
Filing Date |
Trade Date |
Ticker |
Company Name | Insider Name | Title |
Trade Type |
Price |
Qty |
Owned |
ΔOwn |
Value |
1d |
1w |
1m |
6m |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2025-05-16 | PSNL | Personalis, Inc. | Tachibana Aaron | CFO, COO | S - Sale | $4.95 | -1,291 | 165,099 | -1% | -$6,390 | ||||||
2025-05-16 | PSNL | Personalis, Inc. | Moore Stephen Michael | SVP, GC | S - Sale | $4.95 | -1,675 | 64,200 | -3% | -$8,291 | ||||||
2025-05-16 | PSNL | Personalis, Inc. | Chen Richard | Chief Medical Officer, EVP | S - Sale | $4.95 | -910 | 124,957 | -1% | -$4,505 | ||||||
2025-05-19 | GH | Guardant Health, Inc. | Tariq Musa | Dir | S - Sale | $40.04 | -116 | 3,479 | -3% | -$4,645 | ||||||
| D | 2025-05-16 | RDNT | Radnet, Inc. | Forthuber Stephen M | Pres, COO-Eastern Operations | S - Sale+OE | $60.34 | -18,820 | 535,182 | -3% | -$1,135,599 | |||||
2025-05-16 | RDNT | Radnet, Inc. | Levitt Lawrence L | Dir | S - Sale | $61.09 | -5,000 | 164,957 | -3% | -$305,450 | ||||||
| M | 2025-05-16 | BDSX | Biodesix Inc | Schuler Jack W | Dir, 10% | P - Purchase | $0.28 | +4,723,239 | 35,918,174 | +15% | +$1,316,624 | |||||
| D | 2025-05-15 | RDNT | Radnet, Inc. | Hames Norman R | Pres, COO-West Operations | S - Sale+OE | $60.00 | -8,447 | 274,072 | -3% | -$506,820 | |||||
| D | 2025-05-12 | CDNA | Caredx, Inc. | Cournoyer Christine | Dir | S - Sale+OE | $15.96 | -29,136 | 37,045 | -44% | -$465,022 | |||||
| M | 2025-05-12 | DGX | Quest Diagnostics Inc | Delaney Mark E | SVP, Chief Commercial Officer | S - Sale | $175.52 | -1,748 | 7,498 | -19% | -$306,800 | |||||
| M | 2025-05-09 | NTRA | Natera, Inc. | Sheena Jonathan | CO-FOUNDER | S - Sale | $159.25 | -6,070 | 329,408 | -2% | -$966,633 | |||||
| DM | 2025-05-12 | BDSX | Biodesix Inc | Vazquez Chris | Chief Accounting Officer | S - Sale+OE | $0.36 | -224 | 18,001 | -1% | -$80 | |||||
| DM | 2025-05-12 | BDSX | Biodesix Inc | Pestano Gary Anthony | Chief Development Officer | S - Sale+OE | $0.36 | -445 | 156,941 | 0% | -$158 | |||||
| DM | 2025-05-12 | BDSX | Biodesix Inc | O'Kane Kieran | Chief Commercial Officer | S - Sale+OE | $0.36 | -477 | 139,052 | 0% | -$170 | |||||
| DM | 2025-05-12 | BDSX | Biodesix Inc | Hutton Scott | Pres, CEO | S - Sale+OE | $0.36 | -3,775 | 720,384 | -1% | -$1,344 | |||||
| DM | 2025-05-12 | BDSX | Biodesix Inc | Cowie Robin Harper | CFO, Sec'y, Treasurer | S - Sale+OE | $0.36 | -992 | 248,625 | 0% | -$353 | |||||
2025-05-12 | LH | Labcorp Holdings Inc. | Schechter Adam H | Pres, CEO | S - Sale | $248.73 | -6,105 | 98,962 | -6% | -$1,518,497 | ||||||
2025-05-08 | SERA | Sera Prognostics, Inc. | Mirza Mansoor Raza | Dir | S - Sale | $2.44 | -106 | 43,672 | 0% | -$259 | ||||||
2025-05-08 | SERA | Sera Prognostics, Inc. | Lindgardt Zhenya | CEO | S - Sale | $2.44 | -9,406 | 867,251 | -1% | -$22,951 | ||||||
2025-05-08 | SERA | Sera Prognostics, Inc. | Kearney Paul | Chief Data Officer | S - Sale | $2.44 | -7,089 | 196,711 | -3% | -$17,297 | ||||||
2025-05-08 | SERA | Sera Prognostics, Inc. | Jackson Benjamin | GC | S - Sale | $2.44 | -7,084 | 131,460 | -5% | -$17,285 | ||||||
2025-05-08 | SERA | Sera Prognostics, Inc. | Harrison Robert Gardner | CIO | S - Sale | $2.44 | -6,551 | 115,206 | -5% | -$15,984 | ||||||
2025-05-08 | SERA | Sera Prognostics, Inc. | Boniface John J. | Chief Scientific Officer | S - Sale | $2.44 | -5,132 | 165,718 | -3% | -$12,522 | ||||||
2025-05-08 | SERA | Sera Prognostics, Inc. | Aerts Austin | CFO | S - Sale | $2.44 | -6,374 | 303,328 | -2% | -$15,553 | ||||||
2025-05-06 | CDNA | Caredx, Inc. | Cournoyer Christine | Dir | S - Sale | $14.13 | -16,700 | 37,045 | -31% | -$235,929 | ||||||
2025-05-05 | CDNA | Caredx, Inc. | Novack Jeffrey Adam | Secretary, GC | S - Sale | $14.70 | -2,688 | 121,350 | -2% | -$39,514 | ||||||
2025-05-02 | GRAL | Grail, Inc. | Ofman Joshua J. | Pres | S - Sale | $33.93 | -48,213 | 511,460 | -9% | -$1,635,867 | ||||||
| M | 2025-05-01 | GH | Guardant Health, Inc. | Talasaz Amirali | Co-CEO | S - Sale | $49.18 | -120,716 | 2,188,740 | -5% | -$5,936,572 | |||||
2025-05-02 | GRAL | Grail, Inc. | Freidin Aaron | CFO | S - Sale | $33.93 | -41,150 | 294,020 | -12% | -$1,396,220 | ||||||
2025-05-02 | GRAL | Grail, Inc. | Ragusa Robert P | CEO | S - Sale | $33.93 | -94,035 | 734,627 | -11% | -$3,190,608 | ||||||
2025-05-01 | LH | Labcorp Holdings Inc. | Van Der Vaart Sandra D | EVP, GC | S - Sale | $238.36 | -1,900 | 2,244 | -46% | -$452,884 | ||||||
2025-05-01 | LH | Labcorp Holdings Inc. | Wilkinson Peter J | SVP, Chief Accounting Officer | S - Sale | $242.27 | -829 | 2,054 | -29% | -$200,838 | ||||||
2025-05-01 | NTRA | Natera, Inc. | Chapman Steven Leonard | CEO, Pres | S - Sale | $150.10 | -6,980 | 185,182 | -4% | -$1,047,702 | ||||||
2025-05-01 | NTRA | Natera, Inc. | Moshkevich Solomon | Pres, CLINICALDIAGNOSTICS | S - Sale | $150.12 | -3,000 | 136,205 | -2% | -$450,353 | ||||||
| D | 2025-05-01 | NTRA | Natera, Inc. | Marcus Gail Boxer | Dir | S - Sale+OE | $151.61 | -4,000 | 9,704 | -29% | -$606,433 | |||||
2025-04-30 | CDNA | Caredx, Inc. | Maag Peter | Dir | S - Sale | $17.23 | -13,281 | 316,743 | -4% | -$228,796 | ||||||
2025-04-28 | NTRA | Natera, Inc. | Sheena Jonathan | CO-FOUNDER | S - Sale | $152.18 | -439 | 335,478 | 0% | -$66,808 | ||||||
2025-04-28 | NTRA | Natera, Inc. | Rabinowitz Matthew | Exec COB | S - Sale | $152.18 | -1,718 | 2,446,570 | 0% | -$261,449 | ||||||
2025-04-28 | NTRA | Natera, Inc. | Rabinowitz Daniel | SEC., GC | S - Sale | $152.18 | -1,993 | 223,674 | -1% | -$303,300 | ||||||
2025-04-28 | NTRA | Natera, Inc. | Moshkevich Solomon | Pres, CLINICALDIAGNOSTICS | S - Sale | $152.18 | -2,206 | 139,205 | -2% | -$335,714 | ||||||
2025-04-28 | NTRA | Natera, Inc. | Fesko John | Pres, CHIEF BUS. OFFICER | S - Sale | $152.18 | -1,709 | 155,237 | -1% | -$260,080 | ||||||
2025-04-28 | NTRA | Natera, Inc. | Chapman Steven Leonard | CEO, Pres | S - Sale | $152.18 | -6,203 | 192,162 | -3% | -$943,987 | ||||||
| M | 2025-04-28 | NTRA | Natera, Inc. | Brophy Michael Burkes | CFO | S - Sale | $153.39 | -5,063 | 70,494 | -7% | -$776,588 | |||||
| DM | 2025-04-22 | NTRA | Natera, Inc. | Brophy Michael Burkes | CFO | S - Sale+OE | $148.92 | -2,161 | 75,557 | -3% | -$321,809 | |||||
2025-04-21 | CSTL | Castle Biosciences Inc | Maetzold Derek J | Pres, Chief Exec. Officer | S - Sale | $21.52 | -5,644 | 353,631 | -2% | -$121,448 | ||||||
| D | 2025-04-21 | NTRA | Natera, Inc. | Brophy Michael Burkes | CFO | S - Sale+OE | $145.55 | -610 | 76,468 | -1% | -$88,784 | |||||
| D | 2025-04-21 | NTRA | Natera, Inc. | Chapman Steven Leonard | CEO, Pres | S - Sale+OE | $145.55 | -1,664 | 198,365 | -1% | -$242,190 | |||||
2025-04-21 | NTRA | Natera, Inc. | Fesko John | Pres, CHIEF BUS. OFFICER | S - Sale | $145.55 | -343 | 156,946 | 0% | -$49,922 | ||||||
2025-04-21 | NTRA | Natera, Inc. | Moshkevich Solomon | Pres, CLINICALDIAGNOSTICS | S - Sale | $145.56 | -296 | 141,486 | 0% | -$43,085 | ||||||
| D | 2025-04-21 | NTRA | Natera, Inc. | Rabinowitz Daniel | SEC., GC | S - Sale+OE | $145.55 | -470 | 225,667 | 0% | -$68,408 | |||||
| D | 2025-04-21 | NTRA | Natera, Inc. | Sheena Jonathan | CO-FOUNDER | S - Sale+OE | $145.55 | -86 | 335,917 | 0% | -$12,517 | |||||
2025-04-17 | GH | Guardant Health, Inc. | Tariq Musa | Dir | S - Sale | $44.79 | -116 | 3,345 | -3% | -$5,196 | ||||||
| M | 2025-04-08 | CSTL | Castle Biosciences Inc | Maetzold Derek J | Pres, Chief Exec. Officer | S - Sale | $20.19 | -5,644 | 359,275 | -2% | -$113,932 | |||||
2025-04-07 | CDNA | Caredx, Inc. | Jain Abhishek | CFO | S - Sale | $17.72 | -265 | 337,418 | 0% | -$4,696 | ||||||
2025-04-07 | CDNA | Caredx, Inc. | Novack Jeffrey Adam | Secretary, GC | S - Sale | $17.72 | -924 | 126,911 | -1% | -$16,373 | ||||||
2025-04-07 | SERA | Sera Prognostics, Inc. | Mirza Mansoor Raza | Dir | S - Sale | $3.35 | -107 | 43,778 | 0% | -$358 | ||||||
| M | 2025-04-04 | NTRA | Natera, Inc. | Sheena Jonathan | CO-FOUNDER | S - Sale | $136.13 | -6,070 | 335,813 | -2% | -$826,327 | |||||
2025-04-02 | DGX | Quest Diagnostics Inc | Davis J. E. | CEO, Pres | S - Sale | $168.46 | -39,191 | 127,623 | -23% | -$6,602,074 | ||||||
2025-04-02 | DGX | Quest Diagnostics Inc | Kuppusamy Karthik | SVP, Clinical Solutions | S - Sale | $170.00 | -2,555 | 12,546 | -17% | -$434,350 | ||||||
| D | 2025-04-01 | NTRA | Natera, Inc. | Marcus Gail Boxer | Dir | S - Sale+OE | $140.78 | -4,000 | 9,704 | -29% | -$563,100 | |||||
2025-04-01 | NTRA | Natera, Inc. | Moshkevich Solomon | Pres, CLINICALDIAGNOSTICS | S - Sale | $140.48 | -3,000 | 141,782 | -2% | -$421,428 | ||||||
| A | 2025-03-11 | GRAL | Grail, Inc. | Freidin Aaron | CFO | S - Sale | $31.20 | -1,816 | 335,170 | -1% | -$56,659 | |||||
| A | 2025-03-11 | GRAL | Grail, Inc. | Ragusa Robert P | CEO | S - Sale | $31.21 | -7,625 | 828,662 | -1% | -$237,976 | |||||
| A | 2025-03-11 | GRAL | Grail, Inc. | Ofman Joshua J. | Pres | S - Sale | $31.20 | -2,109 | 559,673 | 0% | -$65,801 | |||||
| D | 2025-03-31 | NTRA | Natera, Inc. | Brophy Michael Burkes | CFO | S - Sale+OE | $138.41 | -2,562 | 75,557 | -3% | -$354,603 | |||||
| DM | 2025-03-31 | NTRA | Natera, Inc. | Chapman Steven Leonard | CEO, Pres | S - Sale+OE | $139.70 | -25,461 | 196,643 | -11% | -$3,556,948 | |||||
| D | 2025-03-31 | NTRA | Natera, Inc. | Rabinowitz Daniel | SEC., GC | S - Sale+OE | $138.41 | -1,404 | 225,281 | -1% | -$194,327 | |||||
2025-03-28 | LH | Labcorp Holdings Inc. | Summy Amy B. | EVP, CMO | S - Sale | $231.67 | -758 | 5,302 | -13% | -$175,606 | ||||||
2025-03-28 | LH | Labcorp Holdings Inc. | Schroeder Mark S | EVP, Pres Diagnostics, COO | S - Sale | $231.67 | -2,635 | 4,960 | -35% | -$610,450 | ||||||
2025-03-26 | CSTL | Castle Biosciences Inc | Maetzold Derek J | Pres, Chief Exec. Officer | S - Sale | $20.30 | -5,644 | 364,919 | -2% | -$114,573 | ||||||
2025-03-25 | XGN | Exagen Inc. | Nmsic Co-Investment Fund, L.P. | 10% | S - Sale | $3.30 | -350,000 | 1,758,958 | -17% | -$1,155,000 | ||||||
2025-03-19 | GH | Guardant Health, Inc. | Tariq Musa | Dir | S - Sale | $43.70 | -116 | 3,211 | -3% | -$5,069 | ||||||
2025-03-17 | NTRA | Natera, Inc. | Chapman Steven Leonard | CEO, Pres | S - Sale | $146.03 | -6,702 | 203,354 | -3% | -$978,678 | ||||||
2025-03-17 | NTRA | Natera, Inc. | Brophy Michael Burkes | CFO | S - Sale | $146.04 | -792 | 71,869 | -1% | -$115,661 | ||||||
| M | 2025-03-17 | NTRA | Natera, Inc. | Sheena Jonathan | CO-FOUNDER | S - Sale | $145.62 | -5,881 | 341,883 | -2% | -$856,410 | |||||
2025-03-17 | NTRA | Natera, Inc. | Rabinowitz Matthew | Exec COB | S - Sale | $146.04 | -1,127 | 2,448,288 | 0% | -$164,584 | ||||||
2025-03-17 | NTRA | Natera, Inc. | Rabinowitz Daniel | SEC., GC | S - Sale | $146.04 | -928 | 224,185 | 0% | -$135,521 | ||||||
2025-03-17 | NTRA | Natera, Inc. | Moshkevich Solomon | Pres, CLINICALDIAGNOSTICS | S - Sale | $146.04 | -1,026 | 144,782 | -1% | -$149,836 | ||||||
2025-03-17 | NTRA | Natera, Inc. | Fesko John | Pres, CHIEF BUS. OFFICER | S - Sale | $146.04 | -795 | 157,289 | -1% | -$116,099 | ||||||
2025-03-17 | DGX | Quest Diagnostics Inc | Prevoznik Michael E | SVP, GC | S - Sale | $170.00 | -4,643 | 43,758 | -10% | -$789,310 | ||||||
| M | 2025-03-17 | RDNT | Radnet, Inc. | Hames Norman R | Pres, COO-West Operations | S - Sale | $49.42 | -15,000 | 251,959 | -6% | -$741,300 | |||||
| D | 2025-03-17 | GH | Guardant Health, Inc. | Kalia Kumud | CIO | S - Sale+OE | $43.16 | -3,500 | 19,720 | -15% | -$151,060 | |||||
| D | 2025-03-14 | FTRE | Fortrea Holdings Inc. | Hanson James S. | GC | S - Sale+OE | $9.70 | -1,007 | 9,466 | -10% | -$9,768 | |||||
| D | 2025-03-14 | FTRE | Fortrea Holdings Inc. | Morais Mark A. | COO | S - Sale+OE | $9.70 | -1,207 | 38,672 | -3% | -$11,708 | |||||
| D | 2025-03-14 | FTRE | Fortrea Holdings Inc. | McConnell Jill G. | CFO | S - Sale+OE | $9.70 | -1,210 | 40,467 | -3% | -$11,737 | |||||
2025-03-14 | NTRA | Natera, Inc. | Rabinowitz Matthew | Exec COB | S - Sale | $147.71 | -50,000 | 2,449,415 | -2% | -$7,385,249 | ||||||
| D | 2025-03-12 | NTRA | Natera, Inc. | Marcus Gail Boxer | Dir | S - Sale+OE | $147.69 | -4,000 | 9,704 | -29% | -$590,773 | |||||
| D | 2025-03-13 | FTRE | Fortrea Holdings Inc. | Morais Mark A. | COO | S - Sale+OE | $9.93 | -203 | 35,596 | -1% | -$2,016 | |||||
| D | 2025-03-13 | FTRE | Fortrea Holdings Inc. | McConnell Jill G. | CFO | S - Sale+OE | $9.93 | -261 | 37,394 | -1% | -$2,592 | |||||
| D | 2025-03-12 | FTRE | Fortrea Holdings Inc. | Morais Mark A. | COO | S - Sale+OE | $9.98 | -499 | 35,074 | -1% | -$4,980 | |||||
| D | 2025-03-12 | FTRE | Fortrea Holdings Inc. | McConnell Jill G. | CFO | S - Sale+OE | $9.98 | -643 | 36,720 | -2% | -$6,417 | |||||
2025-03-10 | CDNA | Caredx, Inc. | Bickerstaff George | Dir | S - Sale | $18.36 | -20,000 | 103,027 | -16% | -$367,102 | ||||||
2025-03-07 | GRAL | Grail, Inc. | Ragusa Robert P | CEO | S - Sale | $31.21 | -7,625 | 828,662 | -1% | -$237,976 | ||||||
2025-03-07 | GRAL | Grail, Inc. | Ofman Joshua J. | Pres | S - Sale | $31.20 | -2,109 | 559,673 | 0% | -$65,801 | ||||||
2025-03-07 | GRAL | Grail, Inc. | Freidin Aaron | CFO | S - Sale | $31.20 | -1,816 | 335,170 | -1% | -$56,659 | ||||||
2025-03-07 | RDNT | Radnet, Inc. | Swartz David L | Dir | S - Sale | $50.84 | -25,000 | 211,086 | -11% | -$1,271,000 | ||||||
| M | 2025-03-07 | CSTL | Castle Biosciences Inc | Maetzold Derek J | Pres, Chief Exec. Officer | S - Sale | $20.07 | -29,177 | 370,563 | -7% | -$585,673 | |||||
2025-03-07 | SERA | Sera Prognostics, Inc. | Harrison Robert Gardner | CIO | S - Sale | $4.16 | -3,874 | 121,757 | -3% | -$16,116 | ||||||
| D | 2025-03-07 | SERA | Sera Prognostics, Inc. | Lindgardt Zhenya | CEO | S - Sale+OE | $4.12 | -29,722 | 876,657 | -3% | -$122,455 | |||||
2025-03-07 | SERA | Sera Prognostics, Inc. | Aerts Austin | CFO | S - Sale | $4.12 | -4,818 | 309,702 | -2% | -$19,850 |
| A | Amended filing |
| D | Derivative transaction in filing (usually option exercise) |
| E | Error detected in filing |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |